Hemdan M, Ali MA, Doghish AS, Mageed S, Elazab IM, Khalil MM, et al. Innovations in biosensor technologies for healthcare diagnostics and therapeutic drug monitoring: applications, recent progress, and future research challenges. Sensors. 2024;24:5143.
Article CAS PubMed PubMed Central Google Scholar
Haleem A, Javaid M, Singh RP, Rab S, Suman R. Applications of nanotechnology in medical field: a brief review. Glob Health J. 2023;7:70–77.
Mattioli R, Ilari A, Colotti B, Mosca L, Fazi F, Colotti G. Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Asp Med. 2023;93:101205.
van der Zanden SY, Qiao X, Neefjes J. New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J. 2021;288:6095–111.
Ayodele OO, Adesina AO, Pourianejad S, Averitt J, Ignatova T. Recent advances in nanomaterial-based aptasensors in medical diagnosis and therapy. Nanomaterials. 2021;11:932.
Article CAS PubMed PubMed Central Google Scholar
Bai L, Luo T, Tang J, Zhang J, Tan X, Tang J, et al. Ultrasound‐induced tumor perfusion changes and doxorubicin delivery: a study on pulse length and pulse repetition frequency. J Ultrasound Med. 2024;43:253–63.
Belger C, Abrahams C, Imamdin A, Lecour S. Doxorubicin-induced cardiotoxicity and risk factors. IJC Heart Vasculature. 2024;50:101332.
Hulst MB, Grocholski T, Neefjes J, van Wezel GP, Metsä-Ketelä M. Anthracyclines: biosynthesis, engineering and clinical applications. Nat Product Rep. 2022;39:814–41.
Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine Pharmacotherapy. 2021;139:111708.
Article CAS PubMed Google Scholar
Zhou N, Wei S, Sun T, Xie S, Liu J, Li W, et al. Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. Front Pharmacology. 2023;14:1292088.
Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12:339.
Article CAS PubMed PubMed Central Google Scholar
Elmorsy EA, Saber S, Hamad RS, Abdel-Reheim MA, El-Kott AF, AlShehri MA, et al. Mechanistic insights into carvedilol’s potential protection against doxorubicin-induced cardiotoxicity. Eur J Pharm Sci. 2024;200:106849.
Article CAS PubMed Google Scholar
Ma Y, North BJ, Shu J. Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy. Mol Biol Rep. 2021;48:6589–601.
Article CAS PubMed PubMed Central Google Scholar
Szponar J, Ciechanski E, Ciechanska M, Dudka J, Mandziuk S. Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase. Int J Mol Sci. 2024;25:13567.
Article CAS PubMed PubMed Central Google Scholar
Lozahic, C, Doxorubicin-induced vasotoxicity in coronary vessels: Investigating the G-protein coupled receptor mediated vasoconstriction and the effect of the MEK 1/2 inhibitor U0126. 2023.
Drabczyk A, Kudłacik-Kramarczyk S, Jamroży M, Krzan M. Biomaterials in drug delivery: advancements in cancer and diverse therapies. Int J Mol Sci. 2024;25:3126.
Article CAS PubMed PubMed Central Google Scholar
Cheng X, Xie Q, Sun Y. Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. 2023;11:1177151.
Article PubMed PubMed Central Google Scholar
Feng T, Zhao Y. Nanomaterial-based drug delivery carriers for cancer therapy. Springer; 2017.
Mohammadzadeh V, Rahiman N, Hosseinikhah SM, Barani M, Rahdar A, Jaafari MR, et al. Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: an update. J Drug Delivery Sci Technol. 2022;73:103459.
Khan SA, Akhtar MJ. Structural modification and strategies for the enhanced doxorubicin drug delivery. Bioorganic Chem. 2022;120:105599.
Mobed A, Razavi S, Ahmadalipour A, Shakouri SK, Koohkan G. Biosensors in Parkinson’s disease. Clinica Chim Acta. 2021;518:51–58.
Mobed A, Charsouei S, Yazdani Y, Gargari MK, Ahmadalipour A, Sadremousavi SR, et al. Biosensors, recent advances in determination of BDNF and NfL. Cell Mol Neurobiol. 2023;43:3801–14.
Article PubMed PubMed Central Google Scholar
Rong S, Zou L, Meng L, Yang X, Dai J, Wu M, et al. Dual function metal-organic frameworks based ratiometric electrochemical sensor for detection of doxorubicin. Analytica Chim Acta. 2022;1196:339545.
Zhang Y, Liu S, Ma JL, Chen C, Huang P, Ji JH, et al. Apocynum venetum leaf extract alleviated doxorubicin-induced cardiotoxicity through the AKT/Bcl-2 signaling pathway. Phytomedicine. 2022;94:153815.
Article CAS PubMed Google Scholar
Wang S, Zeng J, Yao X, Mo J. An Nd 3+-sensitized Upconversion Fluorescence Sensor Coupled with Microwell Device for the Ratiometric Detection of Doxorubicin. 2023 IEEE 18th International Conference on Nano/Micro Engineered and Molecular Systems (NEMS). IEEE; 2023.
Jiang K, Tian K, Yu Y, Wu E, Yang M, Pan F, et al. Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin. Nat Commun. 2024;15:6136.
Article CAS PubMed PubMed Central Google Scholar
Narimani R, Esmaeili M, Rasta SH, Khosroshahi HT, Mobed A. Trend in creatinine determining methods: Conventional methods to molecular‐based methods. Anal Sci Adv. 2021;2:308–25.
Article CAS PubMed Google Scholar
Drobysh M, Liustrovaite V, Kanetski Y, Brasiunas B, Zvirbliene A, Rimkute A, et al. Electrochemical biosensing based comparative study of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein. Sci Total Environ. 2024;908:168154.
Article CAS PubMed Google Scholar
Saputra HA. Electrochemical sensors: basic principles, engineering, and state of the art. Monatshefte für Chem - Chem Monthly. 2023;154:1083–1100.
Pour SRS, Calabria D, Emamiamin A, Lazzarini E, Pace A, Guardigli M, et al. Electrochemical vs. optical biosensors for point-of-care applications: a critical review. Chemosensors. 2023;11:546.
Beyrami H, Golshan M, Kucińska-Lipka J, Saeb MR, Salami-Kalajahi M. Chiral-based optical and electrochemical biosensors: Synthesis, classification, mechanisms, nanostructures, and applications. Chem Eng J. 2024;497:155562.
Ran C, Zhang JL, He X, Luo C, Zhang Q, Shen Y, et al. Recent development of Gold nanochips in biosensing and biodiagnosis Sensibilization Strategies in vitro based on SPR, SERS and FRET optical properties. Talanta. 2024;282:126936.
Jarahi Khameneh A, Rahimi S, Abbas MH, Rahimi S, Mehmandoust S, Rastgoo A, et al. Trends in electrochemical biosensors for the early diagnosis of breast cancer through the detection of relevant biomarkers. Chem Phys Impact. 2024;8:100425.
Qazi RA, Aman N, Ullah N, Jamila N, Bibi N. Recent advancement for enhanced e. Coli detection in electrochemical biosensors. Microchemical J. 2024;196:109673.
Sangeetha, P, Ayyanar N, Prabhakar G & Rajaram S Study review of optical biosensors based on 2D materials. Plasmonics, 2025;1–15.
Mpofu K, Chauke S, Thwala L, Mthunzi-Kufa P. Aptamers and antibodies in optical biosensing. Discov Chem. 2025;2:23.
Comments (0)